Girls can buy morning – after pill for now — FDA wins temporary halt on some morning-after pills – An appeals court ordered the U.S. Food and Drug Administration to make certain forms of “morning-after” birth control pills available freely over the counter to anyone who wants to buy them.
AAP Recommends Emergency Contraception Be Available to Teens – Teen pregnancies have declined over the past few decades, but the United States continues to see substantially higher teen birth rates compared to other developed countries. Use of emergency contraception can reduce the risk of pregnancy if used up to 120 hours.
U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management – The U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management.
Male fertility genes discovered — Gene study could pave way for non-hormonal male contraceptive – A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development. The finding could lead to alternatives to conventional male contraceptives that rely on disrupting the production of hormones, such as testosterone and can cause side-effects such as irritability, mood swings and acne.
IUDs, implants most effective birth control – Women who used birth control pills, the patch or vaginal ring were 20 times more likely to have an unintended pregnancy than those who used longer-acting forms such as an intrauterine device (IUD) or implant.
Pfizer Announces Voluntary Nationwide Recall Of Lo/Ovral?-28 And Norgestrel/Ethinyl Estradiol Tablets Due To Possibility Of Inexact Tablet Counts Or Out Of Sequence Tablets – Pfizer Inc. announced that it has voluntarily recalled 14 lots of Lo/Ovral?-28 (norgestrel and ethinyl estradiol)Tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic)for customers in the U.S. market.
Study in Lancet finds use of hormonal contraception doubles HIV risk — University of Washington researchers conducted trial in Africa – Women using hormonal contraception — such as a birth control pill or a shot like Depo-Provera ? are at double the risk of acquiring HIV, and HIV-infected women who use hormonal contraception have twice the risk of transmitting the virus to their HIV-uninfected male partners.
Risk of Venous Thromboembolism in Users of Oral Contraceptives Containing Drospirenone Or Levonorgestrel: Nested Case-Control Study Based on UK General Practice Research Database – Researchers revealed that the combined oral contraceptive containing drospirenone carries a higher risk of venous thromboembolism than do formulations containing levonorgestrel.
Emergency contraception: Advance provision does not reduce pregnancy rates – Providing emergency contraception to women in advance of need does not reduce pregnancy rates, despite increased use and faster use after unprotected se_xual inte_rcourse.